Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes of Straight-line Flow Versus Angiosome-targeted Angioplasty in Treatment of Critical Lower Limb Ischemia

NCT06127134 is registered in ClinicalTrials.gov with Kafrelsheikh University as lead sponsor.

NCT NCT06127134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06127134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes of Straight-line Flow Versus Angiosome-targeted Angioplasty in Treatment of Critical Lower Limb Ischemia
Lead sponsor
Kafrelsheikh University
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2023
Completion date
January 1, 2024
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angioplasty, critical lower limb ischemia